Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MESO stock hub

Mesoblast Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MESOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.9B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MESO

In the news

Latest news · MESO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E113.4

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-18.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-6.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MESO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001345099
Company name	Mesoblast Limited
Country	Australia
Country code	US
Cusip	590717104
Employees	81
Employees Change	8%
Employees Change Percent	10.96
Enterprise value	$1.9B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US5907174016
Last refreshed	2026-05-10
Market cap	$1.9B
Market cap category	Small-Cap
Price	$14.77
Price currency	USD
Rev Per Employee	807,209.88x
Sector	Healthcare
Sic	2836
Symbol	MESO
Website	https://www.mesoblast.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.98%
EV Sales Forward	10.91x
EV/Sales	29.08x
FCF yield	-3.2%
Forward P/E	113.38x
P/B ratio	3.3x
P/S ratio	28.99x
PS Forward	10.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-108.25%
EBITDA Margin	-98.4%
Gross margin	-35.53%
Gross Profit	$-23.2M
Net Income	$-94.4M
Net Income Growth Years	0%
Pretax Margin	-143.47%
Profit Margin	-144.33%
Profit Per Employee	$-1.2M
ROA	-6.16
Roa5y	-6.73
ROCE	-10.82
ROE	-18.22
Roe5y	-17.54
ROIC	-6.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.15%
Cagr15y	-11.93%
Cagr1y	33.69%
Cagr20y	1.27%
Cagr3y	30.01%
Cagr5y	1.14%
EPS Growth Years	4
Revenue Growth	1,053.16x
Revenue Growth Q	1,526.81x
Revenue Growth Years	1x
Revenue Growth3 Y	104.4x
Revenue Growth5 Y	31.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.09
Assets	$782.3M
Cash	$130M
Current Assets	$202.5M
Current Liabilities	$128.1M
Debt	$135.1M
Debt Equity	$0.24
Equity	$574.7M
Interest Coverage	-3.17
Liabilities	$207.6M
Long Term Assets	$579.8M
Long Term Liabilities	$79.6M
Net Cash	$-5.2M
Net Cash By Market Cap	$-0.27
Net Debt Equity	$0.01
Tangible Book Value	$5.9M
Tangible Book Value Per Share	$0
WACC	8.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.58
Inventory Turnover	3.86
Net Working Capital	$13.6M
Quick ratio	1.35
Working Capital	$74.4M
Working Capital Turnover	$1.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-1.53%
1Y total return	33.67%
200-day SMA	16.37
3Y total return	119.79%
50-day SMA	15.16
50-day SMA vs 200-day SMA	50under200
5Y total return	5.8%
All Time High	106.3
All Time High Change	-86.11%
All Time High Date	2011-10-24
All Time Low	1.61
All Time Low Change	817.39%
All Time Low Date	2024-01-18
ATR	0.57
Beta	0.79
Ch YTD	-18.13
High	14.77
High52	21.5
High52 Date	2026-01-09
High52ch	-31.3%
Low	14.51
Low52	9.88
Low52 Date	2025-06-23
Low52ch	49.49%
Ma50ch	-2.54%
Premarket Change Percent	-0.34
Premarket Price	$14.75
Premarket Volume	203
Price vs 200-day SMA	-9.75%
RSI	42.06
RSI Monthly	54.12
RSI Weekly	44.8
Sharpe ratio	0.7x
Sortino ratio	1.2
Tr YTD	-18.13
Tr15y	-85.14%
Tr1m	7.93%
Tr1w	-6.16%
Tr3m	-7.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.2
Earnings Revenue Estimate	17,569,310x
Earnings Revenue Estimate Growth	456.7x
Operating Income	$-70.8M
Operating margin	-108.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	824,599,553%
Float Percent	64%
Net Borrowing	-5,311,000
Shares Insiders	34.9%
Shares Institutions	27.59%
Shares Out	1,288,514,948
Shares Qo Q	1.47%
Shares Yo Y	14.51%
Short Ratio	10.39
Short Shares	3.25

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-76.7M
Average Volume	181,814.8x
Bv Per Share	0.45
CAPEX	$-996,000
Ch10y	-1.53
Ch15y	-85.14
Ch1m	7.93
Ch1w	-6.16
Ch1y	33.67
Ch20y	28.58
Ch3m	-7.4
Ch3y	119.8
Ch5y	5.8
Ch6m	1.1
Change	-0.2%
Change From Open	0.34
Close	14.8
Days Gap	-0.54
Depreciation Amortization	6,439,000
Dollar Volume	1,488,638.8
Earnings Date	2026-02-26
Earnings Time	amc
EBIT	$-70.8M
EBITDA	$-64.3M
EPS	$-0.07
F Score	5
FCF	$-60.6M
FCF EV Yield	-3.19x
FCF Per Share	$-0.05
Financing CF	150,472,000
Fiscal Year End	June
Founded	2,004
Goodwill	134,453,000
Income Tax	$563,000
Investing CF	-1,114,000
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Last Split Date	2024-01-10
Last Split Type	Reverse
Last10k Filing Date	2025-08-29
Ma150	16.65
Ma150ch	-11.31%
Ma20	15.59
Ma20ch	-5.26%
Net CF	91,946,000
Next Earnings Date	2026-08-27
Open	14.72
Optionable	Yes
Position In Range	100
Post Close	14.77
Postmarket Change Percent	-1.4
Postmarket Price	$14.56
Ppne	8,279,000
Pre Close	14.8
Price Date	2026-05-08
Ptbv Ratio	322.1
Relative Volume	0.55x
Revenue	65,384,000x
SBC By Revenue	24.5x
Share Based Comp	16,018,000
Tax By Revenue	0.86x
Tr20y	28.58%
Tr6m	1.1%
Volume	100,788
Z Score	3.45

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MESO pay a dividend?

Capital-return profile for this ticker.

Performance

MESO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MESO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+27.6%

Float: +64.0% of shares outstanding

Insider ownership

+34.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MESO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.1

Neutral momentum band

Price vs 200-day MA

-9.7%

50/200-day relationship not available

Beta (5Y)

0.79

Less volatile than the market

Sharpe ratio

0.70

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MESO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MESO stock rating?

Mesoblast Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MESO analysis?

The full report lives at /stocks/MESO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MESO?

The latest report frames MESO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MESO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.